Over 60 Firms Confirmed to Attend CBI’s Third Annual Bio/Pharmaceutical Collaboration and Transaction Accounting Conference in September

PDF  | Print  | E-mail

Boston, MA, August 27, 2009 — The Center for Business Intelligence (CBI), a division of Advanstar Communications, is pleased to announce their full agenda for the 3rd Annual Bio/Pharmaceutical Collaboration and Transaction Accounting. Over 60 firms are already confirmed to gather in Philadelphia on September 22nd for this one-day seminar to hear expert insights and discuss industry case examples for accounting for collaborations and transactions. Perspectives on FASB, IFRS and US GAAP, plus updates on the impact of EITF 07-1, EITF 99-19, EITF 00-21, EITF 07-3 and EITF 08-A will be presented.

The FASB and SEC are considering refinements to the collaboration accounting model. This, coupled with the trend of IFRS convergence, make it critical that life science companies master the financial accounting and reporting of deal-making activities. Amidst changing regulations, top executives from companies such as Goldman Sachs, FASB, GlaxoSmithKline, Infinity Pharmaceuticals and Johnson & Johnson will examine:

• Recent Mergers and Acquisitions Impacting the Pharmaceutical Sector
• Examples of Exotic Financings in Life Sciences
• Trends in Deal Values and Economic Factors in Assessing and Valuing Innovation
• Milestones and Revenue Arrangements with Multiple Deliverables
• EITF Updates on Revenue Recognition and Capitalization of Milestone Payments
• Considerations from a JFC Perspective for Joint Steering Committees (JSCs) and Other Joint Collaboration Meetings
• FASB Accounting Guidelines for Collaborative Arrangements and Revenue Recognition

If you would like to view the full agenda, please visit this page. A “best-in-class” reputation, CPE credits and professional networking make this an extremely worthwhile event. For more information on this event, please visit http://www.cbinet.com/collaboration. If you would like to apply for a press pass, please contact Erica Kirwan of CBI at 339.298.2263.

About CBI:

A subsidiary of Advanstar Communications, CBI Research, Inc. offers Pharmaceutical and Healthcare conferences that serve senior executives and government officials by providing a unique platform for highly focused content and ideal networking opportunities with senior policy- and decision-makers. CBI events provide you with concrete, real-life examples that you can begin to apply at your organization immediately for significant impact on costs and revenue. sFor more information, please visit http://www.cbinet.com.

Other press releases from The Center for Business Intelligence

• John F. Crowley, Chairman & CEO, Amicus Therapeutics, to Keynote CBI’s 5th Annual Rare Disease Leadership Summit - May 5th, 2010
• CBI Announces Agenda for 9th Annual Forum on Patient Adherence, Compliance and Persistency - February 23rd, 2010
• CBI Announces the Agenda for Their 6th Annual Pharmaceutical/Biotech Accounting and Reporting Congress - December 15th, 2009
• CBI and Medical Meetings Magazine Announce Agenda for 6th Annual Pharmaceutical Meeting Management Forum - December 3rd, 2009
• CBI Announces Agenda and Keynote Speaker for The 9th Annual Strategic Medicare Policy Summit - December 2nd, 2009
• CBI Announces FDA Participation at Upcoming Forum on Clinical Trial Investigator Portals - October 28th, 2009
• CBI Announces Keynote Panel Discussion on Learning from the Pharma Meeting Planner at Upcoming Conference on Evolving Hotel Sale Strategies for Hotels Targeting the Life Science Industry - October 19th, 2009
• Marc J. Fagel of the U.S. Securities and Exchange Commission to Discuss SEC Enforcement at CBI’s Biotech/Pharma Finance and Accounting Forum in San Francisco - October 7th, 2009
• CBI Announces the Agenda for its Forum on FDA’s Structured Product Labeling (SPL R4) - September 29th, 2009
• CBI Hosts 11th Annual Guidelines on Disseminating Off-Label Information - September 23rd, 2009

Email This Press Release